TII
26.10.2021 10:21:09 CEST | Business Wire | Press release
Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), today announced that its Secure Systems Research Centre (SSRC) has partnered with three prestigious universities on secure mesh communications research projects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211026005550/en/
Mesh network is a network topology in which the infrastructure nodes connect directly, dynamically, and non-hierarchically to as many other nodes as possible, and cooperate with one another to efficiently route data to and from third parties. The project is set to strengthen the security of the Mesh network technology that TII is currently developing for machine to machine and human to human communications.
The three partner universities include the UAE’s Khalifa University of Science and Technology , a world-class research institution that nurtures critical thinkers in applied science and engineering, University of Turku in Turku, Finland, and Graz University of Technology (TU Graz) in Styria, Austria. The Khalifa University project is titled ‘A Secure and Resilient Chat/VoIP Application over Private Mesh Networks’. Meanwhile, the University of Turku project focuses on ‘R3Swarms: Robust, Resilient and Reconfigurable Swarms’, and the project with TU Graz is titled ‘SPiDR: Secure, Performant, Dependable, and Resilient Wireless Mesh Networks’.
Speaking on the significance of this development for the UAE and the wider region, Dr Shreekant (Ticky) Thakkar, Chief Researcher at SSRC , said: “In the UAE we conduct research to provide technology that improves life through making systems and communications safer. This is of the utmost importance when technologies combine human, physical systems, and software interactions. Mesh Network Research conducted with our partners in Turku University, TU Graz, and Khalifa University will accelerate the deployment of safe communication for the benefit of people living in the UAE and the wider region.”
Dr Thakkar said the collaborations with Turku University and TU Graz will span the domain of communication resilience improvement through exploring, among other aspects, UWB (Ultra-wideband) transmissions, while the partnership with Khalifa University focuses on PHY (Physical layer) security and secure routing. A total of four research programmes are getting underway to provide a significant improvement in the ability of Mesh Networks to resist eavesdropping, scanning, malware propagation and jamming, among other threats. As a direct application, these benefits are critical for cyber physical system swarm communications to become credible and resilient when operating autonomously, Dr Thakkar added.
He noted that dependable and secure Mesh Networks are an integral part of overall communication infrastructure and will enable secure autonomous systems.
Dr Carlo Boano, Associate Professor, Institute of Technical Informatics, TU Graz, said: “The technologies developed within SPiDR will empower off-the-shelf drones and smartphones with the ability to autonomously detect and mitigate malicious attacks and coexistence problems, thereby increasing their availability and functionality without adding to the costs of operating them.”
Dr Tomi Westerlund, Associate Professor, Smart Systems at University of Turku, said: “The project with SSRC focuses on exploiting and advancing state-of-the-art technologies including, but not limited to, DL, DLT, and UWB, as the basis to design and build more secure, flexible, robust, resilient, and reconfigurable swarms.”
For his part, Dr Hadi Otrok, Associate Professor, Department of Electrical Engineering and Computer Science at Khalifa University, said: “Through this project, we aim to build efficiencies and address earlier shortcomings by developing efficient chat and VoIP applications within secure and resilient Mesh Networks.”
For more information, visit www.tii.ae
*Source: AETOSWire
View source version on businesswire.com: https://www.businesswire.com/news/home/20211026005550/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom